Granisetron.
Nodoushani
M
M
Department of Pharmacy Services, Hartford Hospital, USA.
D000970:Antineoplastic Agents / Q000009:adverse effects; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D017829:Granisetron / Q000191:economics / Q000494:pharmacology / Q000627:therapeutic use; D009325:Nausea / Q000139:chemically induced / Q000188:drug therapy; D014839:Vomiting / Q000139:chemically induced / Q000188:drug therapy
D000970:Antineoplastic Agents; D017829:Granisetron